RedCarpetLife
1025
In the world today
Maurizio Billi

Maurizio Billi

M. Billi
0.57% | + $23.34M
$4.11 B ₹ 37,404 Cr
Real Time Net Worth #1025 Ranking as of 21 Feb 2026 By Forbes

More on Maurizio Billi

Gender

Male

Age

68Y

Country

Brazil

Born On

November, 1957

Deceased

No

Relationship Status

Married

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

No

Entrepreneur Type

Inherited (Pharmaceuticals)

Primary Organization

Eurofarma

Titles

President

Sources of Wealth

Eurofarma

Industry

Healthcare, Pharmaceuticals

About Maurizio Billi


M aurizio Billi is the president and controlling shareholder of Eurofarma, a Brazilian pharmaceutical giant headquartered in São Paulo. Founded in 1972 by his father, Galliano Billi, the company has grown into one of the largest drug manufacturers in Brazil, known for producing generic versions of popular medications. Maurizio Billi joined the family business at a young age and was instrumental in its expansion, particularly its strategy of acquiring smaller laboratories across Latin America.

Under his leadership, Eurofarma has established a presence in over 20 countries, becoming a regional powerhouse in the pharmaceutical sector. Billi has focused on modernizing the company's production facilities and investing in research and development. He is also a passionate car racing enthusiast, owning a stock car racing team that competes in Brazil's premier motorsport series. His wealth is derived from his ownership of the privately held company, which continues to dominate the generic drug market in Brazil.

Advertisement

Quick Reads


Early Life and Background


Maurizio Billi is a Brazilian businessman and billionaire, the President of Eurofarma, one of the largest pharmaceutical companies in Brazil. The company was founded by his father in 1972 and specializes in selling generic versions of drugs.

Eurofarma has expanded its operations to 22 countries across Central and South America and employs more than 12,600 people. The company reports over $1.8 billion in revenues.

  • Core Company: Eurofarma, one of Brazil's largest pharmaceutical companies.
  • Founding: Founded by his father in 1972.
  • Scale: Operates in 22 countries and employs over 12,600 people.

Career Journey of Maurizio Billi


Maurizio Billi's career has been dedicated to scaling Eurofarma into a multinational pharmaceutical enterprise. Under his leadership, Eurofarma aggressively expanded across Central and South America by acquiring medical suppliers, labs, and other pharmaceutical companies.

His structural contribution is tied to making essential medicines, including generic versions of drugs such as Viagra, accessible across a vast region. His wealth is secured by the immense regional scale and profitability of the pharmaceutical giant.

Advertisement

Maurizio Billi's Timeline


1972:

Father founds Eurofarma.

Ongoing:

Eurofarma expands to 22 countries through strategic acquisitions.

Ongoing:

Continues as President, guiding the pharmaceutical giant.

Major Business Ventures and Investments


Maurizio Billi's wealth is concentrated in his controlling stake and continued leadership of the private pharmaceutical giant, Eurofarma.

  • Eurofarma (President): One of the largest pharmaceutical companies in Brazil, with over $1.8 billion in revenues.
  • Products: Focuses on generic versions of drugs and pharmaceuticals.
  • Geographic Reach: Operates in 22 countries in Central and South America.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is the President of Eurofarma, one of the largest pharmaceutical companies in Brazil.
  • Eurofarma sells generic versions of drugs.
  • The company operates in 22 countries and employs more than 12,600 people.

Advertisement

More Profiles


Ugo Gussalli Beretta & family

+0.21% | +$6.20M

Beda Diethelm

+0.13% | +$3.04M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content